NCT05522894 2022-08-31
AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC
ChineseAMS
Phase 2 Unknown
Clinical Trials
9 trialsNCT03083613 2021-02-01
Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT02858206 2019-07-26
Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
ChineseAMS
Phase 2 Unknown
NCT03735082 2018-11-08
Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT02133612 2015-04-14
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase 2 Completed
NCT02041338 2014-11-25
Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT01797900 2014-09-10
The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
ChineseAMS
Phase 2 Completed
NCT01444547 2014-05-06
A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin
ChineseAMS
Phase 2 Unknown
NCT01276769 2011-11-16
Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer
ChineseAMS
Phase 2 Unknown